BeOne Medicines Forecast, price target & analysts
BeOne Medicines Target price 2025 - Analyst rating & recommendation
BeOne Medicines Classifications & Recommendation:
BeOne Medicines Price Target
| Target Price | CNY317.22 |
| Price | CNY323.20 |
| Deviation |
1.85%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target BeOne Medicines 2026 .
The average BeOne Medicines target price is CNY317.22.
This is
1.85%
register free of charge
CNY371.28
14.88%
register free of charge
CNY278.76
13.75%
register free of charge
|
|
| A rating was issued by 14 analysts: 13 Analysts recommend BeOne Medicines to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the BeOne Medicines stock has an average upside potential 2026 of
1.85%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion CNY | 27.21 | 37.17 |
| 56.19% | 36.59% | |
| EBITDA Margin | -13.43% | 4.69% |
| 72.09% | 134.91% | |
| Net Margin | -18.29% | 3.00% |
| 52.54% | 116.40% |
9 Analysts have issued a sales forecast BeOne Medicines 2025 . The average BeOne Medicines sales estimate is
This results in the following potential growth metrics:
8 BeOne Medicines Analysts have issued a net profit forecast 2025. The average BeOne Medicines net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share CNY | -3.64 | 0.78 |
| 26.46% | 121.43% | |
| P/E | 407.08 | |
| EV/Sales | 7.74 |
8 Analysts have issued a BeOne Medicines forecast for earnings per share. The average BeOne Medicines EPS is
This results in the following potential growth metrics and future valuations:
BeOne Medicines...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
